 My name is Mathieu Rahman. I work as head of the laboratory at Oxford University Clinical Research Unit in Ho Chi Minh City. My responsibility is to run a laboratory operation program across Okru units in Vietnam, Indonesia and Nepal. We have been conducting research on tuberculosis, dengue, malaria, brain infection, hepatitis for last decades. We have been using advanced genomics for early diagnosis and detection of antimicrobial resistance in mycobacterium that has been very successful. We have been monitoring antimicrobial resistance in malarial parasite for last 20-plus years. We also maintain insectarium where we grow mosquito and then we use this mosquito to infect dengue patient to see how long a patient can remain infected to the mosquitoes. We oversee actually three different types of laboratories. We call it general biosafety level 2 laboratory which deals with most of the pathogen we generally work with. Then we have a biosafety level 3 laboratory which is mainly for dangerous pathogens. And then we also have a specified animal pathogen 4, order 4 laboratory which is a high risk pathogen for zoonotic infections. So we have several programs and our research projects are conducted through many different provincial hospitals. So every hospital we work with we train the staff in those hospitals. We try to transfer technology. We bring the staffs from there to come to visit our place. And then we also recruit MSC and PhD students who work in our laboratory. So capacity building is like as a part of our laboratory program that continues all the time. When we do research on tuberculosis we look for ways in which we can diagnose the disease quickly and more accurately. So we took research projects that particularly deals with early diagnosis and then to detect antimicrobial resistance simultaneously so that the patient can be prescribed with the right medicine in time. We have been conducting research on personalized medicine for tuberculosis in which we identify the patient's genotype and then treat them based on that particular genotype which gives us much accurate treatment. Our research studies on tuberculosis has changed or helped millions in the world to get right diagnosis and the right treatment in time. Our antimicrobial resistance monitoring program taking a one health approach has helped Vietnam in reducing antimicrobial use in livestock, poultry, fisheries and has contributed significantly in reducing antimicrobial resistance problem in Vietnam. Research to practice to research is one of our key objectives when we conduct research. So if we look at our clinical trials where the treatment option, treatment duration and treatment regime is being defined is directly translated into patient management locally and then those results has later been translated into policy and contributed in patient management. So whatever we do here in Vietnam those are very much translational research and the intent is to change local policy.